Samabriva is a biotechnology company specializing in the development of biotherapeutics. It provides a RhizoBriva platform that is a bioreactor-confined plant-based bioprocessing technology allowing the production of biomolecules suitable for the pharmaceutical, cosmetics, agrochemicals, and food industries. The company also offers a NanoBriva platform that enables the design and production of recombinant therapeutic proteins, such as lysosomal enzymes, for the treatment of rare diseases.